Iron Oxide Nanozyme: A Multifunctional Enzyme Mimetics for Biomedical Application. In: Yan X, editor. Nanozymology. Singapore: Springer; 2020. pp. 105-40. [DOI: 10.1007/978-981-15-1490-6_5]

When nanozymes meet enzyme: Unlocking the dual-activity potential of integrated biocomposites

Integrating enzymes and nanozymes in various applications is a topic of significant interest. The researchers have explored the encapsulation of enzymes using diverse nanostructures to create nanomaterial-enzyme hybrids. These nanomaterials introduce unique properties that contribute to the additional activity along with the stabilization of enzymes in immobilized form, enabling a cascade of second-order reactions. This review centers on dual-activity nanozymes, providing insights into their applications in biosensors and biocatalysis. These applications leverage the enhanced catalytic activity and stability offered by dual-activity nanozymes. These nanozymes find promising applications in fields like bioremediation, offering eco-friendly solutions for mitigating environmental pollution while showing potential in medical diagnostics. The review delves into various techniques for creating enzyme-nanozyme hybrid catalysts, including adsorption, encapsulation, and incorporation methods. The review also addresses the challenges that must be overcome, such as overlapping catalytic surfaces and disparities in reaction rates in multi-enzyme cascade reactions. It concludes by presenting strategies to tackle these issues and offers insights into the field's promising future, suggesting that machine learning may drive further advancements in enzyme-nanozyme integration. This comprehensive exploration illuminates the present and charts a promising course for future innovations in the seamless integration of enzymes and nanozymes, heralding a new era of catalytic possibilities.

Fe-Curcumin Nanozyme-Mediated Reactive Oxygen Species Scavenging and Anti-Inflammation for Acute Lung Injury

Pneumonia, such as acute lung injury (ALI), has been a type of lethal disease that is generally caused by uncontrolled inflammatory response and excessive generation of reactive oxygen species (ROS). Herein, we report Fe-curcumin-based nanoparticles (Fe-Cur NPs) with nanozyme functionalities in guiding the intracellular ROS scavenging and meanwhile exhibiting anti-inflammation efficacy for curing ALI. The nanoparticles are noncytotoxic when directing these biological activities. Mechanism studies for the anti-inflammation aspects of Fe-Cur NPs were systematically carried out, in which the infected cells and tissues were alleviated through downregulating levels of several important inflammatory cytokines (such as TNF-α, IL-1β, and IL-6), decreasing the intracellular Ca2+ release, inhibiting NLRP3 inflammasomes, and suppressing NF-κB signaling pathways. In addition, we performed both the intratracheal and intravenous injection of Fe-Cur NPs in mice experiencing ALI and, importantly, found that the accumulation of such nanozymes was enhanced in lung tissue (better than free curcumin drugs), demonstrating its promising therapeutic efficiency in two different administration methods. We showed that the inflammation reduction of Fe-Cur NPs was effective in animal experiments and that ROS scavenging was also effectively achieved in lung tissue. Finally, we revealed that Fe-Cur NPs can decrease the level of macrophage cells (CD11bloF4/80hi) and CD3+CD45+ T cells in mice, which could help suppress the inflammation cytokine storm caused by ALI. Overall, this work has developed the strategy of using Fe-Cur NPs as nanozymes to scavenge intracellular ROS and as an anti-inflammation nanodrugs to synergistically cure ALI, which may serve as a promising therapeutic agent in the clinical treatment of this deadly disease. Fe-Cur NP nanozymes were designed to attenuate ALI by clearing intracellular ROS and alleviating inflammation synergistically. Relevant cytokines, inflammasomes, and signaling pathways were studied.

Pd-Fe3O4 Janus nanozyme with rational design for ultrasensitive colorimetric detection of biothiols

Although nanozyme-based colorimetric assays have been broadly used for biosensing, some limitations such as low catalytic activity of nanozyme, poor sensitivity to analytes and lack of understanding the structure-activity relationship remain unsolved. In this work, we developed an ultrasensitive colorimetric method for biothiols detection based on density functional theory-assisted design of janus Pd-Fe₃O₄ nanozyme. The Pd-Fe₃O₄ dumbbell-like nanoparticles (DBNPs) prepared by seed-mediated approach shows a uniform heterodimeric nanostructure. Ultrasensitive biothiols detection is achieved from two aspects. On one hand, due to the synergistic effect between Pd and Fe₃O₄ in the dumbbell structure, Pd-Fe₃O₄ DBNPs show enhanced peroxidase-mimic activity compared to the individual components. On the other hand, when the target biothiols molecule is present, its inhibition effect on the janus Pd-Fe₃O₄ nanozyme is also significantly enhanced. The above results are confirmed both in experiment and theoretical calculation. Based on the rational design, a simple, highly selective and urtrasensitive colorimetric and quantitative assay for biothiols is developed. The limit of detection (LOD) can reach as low as 3.1 nM in aqueous solution. This assay is also successfully applied to the detection of biothiols in real urine samples. Moreover, the Pd-Fe₃O₄ nanozyme is used to discriminate biothiols levels in normal and cancer cells with high sensitivity at the cell density of 15,000/mL, which demonstrates its great potential in biological and clinical analysis. This work not only shows the great promise of janus bimetallic nanozymes' excellent functionalities but also provides rational guidelines to design high-performance nanozymes for biosensing and biomedical applications.

Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-dysfunction-associated fatty liver disease (MAFLD), affects a quarter of the worldwide population. Natural products have been extensively utilized in treating NAFLD because of their distinctive advantages over chemotherapeutic drugs, despite the fact that there are no approved drugs for therapy. Notably, the limitations of many natural products, such as poor water solubility, low bioavailability in vivo, low hepatic distribution, and lack of targeted effects, have severely restricted their clinical application. These issues could be resolved via hepatic targeted drug delivery systems (HTDDS) that boost clinical efficacy in treating NAFLD and decrease the adverse effects on other organs. Herein an overview of natural products comprising formulas, single medicinal plants, and their crude extracts has been presented to treat NAFLD. Also, the clinical efficacy and molecular mechanism of active monomer compounds against NAFLD are systematically discussed. The targeted delivery of natural products via HTDDS has been explored to provide a different nanotechnology-based NAFLD treatment strategy and to make suggestions for natural-product-based targeted nanocarrier design. Finally, the challenges and opportunities put forth by the nomenclature update of NAFLD are outlined along with insights into how to improve the NAFLD therapy and how to design more rigorous nanocarriers for the HTDDS. In brief, we summarize the up-to-date developments of the NAFLD-HTDDS based on natural products and provide viewpoints for the establishment of more stringent anti-NAFLD natural-product-targeted nanoformulations.

Nanozyme Catalytic Turnover and Self-Limited Reactions

Enzymes have catalytic turnovers. The field of nanozyme endeavors to engineer nanomaterials as enzyme mimics. However, a discrepancy in the definition of "nanozyme concentration" has led to an unrealistic calculation of nanozyme catalytic turnovers. To date, most of the reported works have considered either the atomic concentration or nanoparticle (NP) concentration as nanozyme concentration. These assumptions can lead to a significant under- or overestimation of the catalytic activity of nanozymes. In this article, we review some classic nanozymes including Fe₃O₄, CeO₂, and gold nanoparticles (AuNPs) with a focus on the reported catalytic activities. We argue that only the surface atoms should be considered as nanozyme active sites, and then the turnover numbers and rates were recalculated based on the surface atoms. According to the calculations, the catalytic turnover of peroxidase Fe₃O₄ NPs is validated. AuNPs are self-limited when performing glucose-oxidase like activity, but they are also true catalysts. For CeO₂ NPs, a self-limited behavior is observed for both oxidase- and phosphatase-like activities due to the adsorption of reaction products. Moreover, the catalytic activity of single-atom nanozymes is discussed. Finally, a few suggestions for future research are proposed.

Nanozyme Applications: A Glimpse of Insight in Food Safety

Nanozymes own striking merits, including high enzyme-mimicking activity, good stability, and low cost. Due to the powerful and distinguished functions, nanozymes exhibit widespread applications in the field of biosensing and immunoassay, attracting researchers in various fields to design and engineer nanozymes. Recently, nanozymes have been innovatively used to bridge nanotechnology with analytical techniques to achieve the high sensitivity, specificity, and reproducibility. However, the applications of nanozymes in food applications are seldom reviewed. In this review, we summarize several typical nanozymes and provide a comprehensive description of the history, principles, designs, and applications of nanozyme-based analytical techniques in food contaminants detection. Based on engineering and modification of nanozymes, the food contaminants are classified and then discussed in detail via discriminating the roles of nanozymes in various analytical methods, including fluorescence, colorimetric and electrochemical assay, surface-enhanced Raman scattering, magnetic relaxing sensing, and electrochemiluminescence. Further, representative examples of nanozymes-based methods are highlighted for contaminants analysis and inhibition. Finally, the current challenges and prospects of nanozymes are discussed.

Heterojunction of Vertically Arrayed MoS2 Nanosheet/N-Doped Reduced Graphene Oxide Enabling a Nanozyme for Sensitive Biomolecule Monitoring

Enzymes are still indispensable for bio-assaying methods in biomolecule detection by far. The unsatisfied long-term instability, high cost, and susceptibility to the physical environment of natural enzymes are obvious weak points. Here, we developed peroxidase-like heterostructured nanozyme, vertically arraying molybdenum disulfide nanosheets on a substrate layer of nitrogen-doped reduced graphene oxide (MoS₂/N-rGO), with a well-pleasing stability that is characterized by the retained enzymatic activity and maintained structure after 2 years of casual storage at ambient temperatures or 80 cycles of catalytic reaction. The catalytic kinetics of the as-prepared heterostructured nanozyme was superior to some reported nanozymes and even horse radish peroxidase, which was demonstrated due to the defect-rich MoS₂ with Mo and S vacancies and nitrogen-doped rGO experimentally and theoretically. The vertically heterostructured nanozyme exhibited adequate analytical performance in sensitive and quantitative detection of glucose and glutathione (GSH), with a large dynamic sensing range and extremely low limit of detection (0.02 and 0.12 μM (3σ/slope) for glucose and GSH, respectively). We hope this inspired artificial nanozyme will contribute to the future development in sensitive detection of other biomolecules in physiological conditions.

Nanozyme for tumor therapy: Surface modification matters

As the next generation of artificial enzymes, nanozymes have shown unique properties compared to its natural counterparts, such as stability in harsh environment, low cost, and ease of production and modification, paving the way for its biomedical applications. Among them, tumor catalytic therapy mediated by the generation of reactive oxygen species (ROS) has made great progress mainly from the peroxidase-like activity of nanozymes. Fe₃O₄ nanozymes, the earliest type of nanomaterial discovered to possess peroxidase-like activity, has consequently received wide attention for tumor therapy due to its ROS generation ability and tumor cell killing ability. However, inconsistent results of cytotoxicity were observed between different reports, and some even showed the scavenging of ROS in some cases. By collectively studying these inconsistent outcomes, we raise the question whether surface modification of Fe₃O₄ nanozymes, either through affecting peroxidase activity or by affecting the biodistribution and intracellular fate, play an important role in its therapeutic effects. This review will go over the fundamental catalytic mechanisms of Fe₃O₄ nanozymes and recent advances in tumor catalytic therapy, and discuss the importance of surface modification. Employing Fe₃O₄ nanozymes as an example, we hope to provide an outlook on the improvement of nanozyme-based antitumor activity.

Green Synthesis: An Eco-friendly Route for the Synthesis of Iron Oxide Nanoparticles

Green approach has received major attention for the synthesis of metal oxide nanoparticles. One such metal oxide nanoparticles are iron oxide nanoparticles (IONPs). IONPs have fetched a great deal of interest in recent era because of their magnetic nature, as they can be easily recovered from the reaction mixture by applying an external magnetic field. Although, a variety of chemical and physical methods of synthesis are known, green synthesis is safer, sustainable and biologically acceptable. Plants and microbes are the main biological materials used for the green synthesis. In present review, the synthesis of IONPs by using plants, bacteria, fungi and algae have been highlighted. IONPs produced by plants, fungi, bacteria and algae usually falls in 1–100 nm range and are of distinct shapes like cubic, tetragonal crystalline, spherical, cylindrical, elliptical, octahedral, orthorhombic, hexagonal rods, nanosphere and quasi spherical. Furthermore, these biomaterials play role of reducing, capping, stabilizing and fabricating agents in green synthesis of nanoparticles. The review put forward a comprehensive report of various routes used for synthesizing IONP, biologically. Intuition into the procedures for synthesis of nanoparticles will help to nourish our learning in the area of nanotechnology.

Mechanistic Aspects of Microbe-Mediated Nanoparticle Synthesis

In recent times, nanoparticles (NPs) have found increasing interest owing to their size, large surface areas, distinctive structures, and unique properties, making them suitable for various industrial and biomedical applications. Biogenic synthesis of NPs using microbes is a recent trend and a greener approach than physical and chemical methods of synthesis, which demand higher costs, greater energy consumption, and complex reaction conditions and ensue hazardous environmental impact. Several microorganisms are known to trap metals in situ and convert them into elemental NPs forms. They are found to accumulate inside and outside of the cell as well as in the periplasmic space. Despite the toxicity of NPs, the driving factor for the production of NPs inside microorganisms remains unelucidated. Several reports suggest that nanotization is a way of stress response and biodefense mechanism for the microbe, which involves metal excretion/accumulation across membranes, enzymatic action, efflux pump systems, binding at peptides, and precipitation. Moreover, genes also play an important role for microbial nanoparticle biosynthesis. The resistance of microbial cells to metal ions during inward and outward transportation leads to precipitation. Accordingly, it becomes pertinent to understand the interaction of the metal ions with proteins, DNA, organelles, membranes, and their subsequent cellular uptake. The elucidation of the mechanism also allows us to control the shape, size, and monodispersity of the NPs to develop large-scale production according to the required application. This article reviews different means in microbial synthesis of NPs focusing on understanding the cellular, biochemical, and molecular mechanisms of nanotization of metals.

Regeneration and reuse of magnetic particles for contaminant degradation in water

Fenton reaction is an oxidation process of interest in wastewater treatment because of its ability to degrade organic compounds. Iron-based magnetic particles can be a very useful catalyst when using heterogeneous Fenton process. The major problem of this heterogeneous process is the saturation of the Fe ³⁺ on the surface, which limits the process. In this study, the possibility of using magnetite particles as a substrate is presented, increasing its degradation efficiency by Fenton reaction through a regeneration process that achieves the electronic reduction of its surface using reducing agents. The results indicate that the regeneration process is quite effective, increasing the efficiency of the degradation of Methylene Blue up to 99%. The concentration of magnetite is the most influential factor in the efficiency of the reaction, while the regeneration time and the concentration of reducing agent do not significantly affect the results considering the range used. The presence of mechanical stirring may adversely affect the reaction in the long term. Increasing the oxidant agent concentration reduces the initial speed of the reaction but not the long-term efficiency. The use of hydrazine in this process allows the successive reuse of these particles maintaining a high percentage of elimination of methylene blue, above 70% even after 10 uses, compared to an elimination below 20% for particles not regenerated after the second use and for particles regenerated with ascorbic acid after the eighth use.

In vivo guiding inorganic nanozymes for biosensing and therapeutic potential in cancer, inflammation and microbial infections

Researchers have recently introduced some artificial enzymes based on nanomaterials that show significant catalytic activity relative to native enzymes called nanozyme. These nanozymes show superior performance than conventional catalysts and are considered as fascinating candidates for introducing the next generation of biomaterials in various industrial and biomedical fields. Recently, nanozymes have received a great deal of attention in biomedical applications due to their potential properties such as long-term stability, low cost, mass production capability, and controllable catalytic activity. Due to the intrinsic catalytic activity of nanoparticles (NPs) as nanozymes and their ability to be regulated in biomedical processes, this review paper focuses on the in vivo applications of nanozymes in biosensing and therapeutic activities. Despite the challenges and benefits of each approach, this paper attempts to provide an appropriate motivation for the classification of different nanozymes followed by their application in biomedical activities including in vivo biosensing and therapeutic potential in cancer, inflammation and microbial infections. Finally, some ongoing challenges and future perspective of nanozymes in biomedical application were surveyed. In conclusion, this paper may provide useful information regarding the development of nanozymes as promising platforms in biomedical settings due to expedited diagnosis, the advancement of multifactorial therapies and their pronounced stability.

Cell primitive-based biomimetic functional materials for enhanced cancer therapy

Cell primitive-based functional materials that combine the advantages of natural substances and nanotechnology have emerged as attractive therapeutic agents for cancer therapy. Cell primitives are characterized by distinctive biological functions, such as long-term circulation, tumor specific targeting, immune modulation etc. Moreover, synthetic nanomaterials featuring unique physical/chemical properties have been widely used as effective drug delivery vehicles or anticancer agents to treat cancer. The combination of these two kinds of materials will catalyze the generation of innovative biomaterials with multiple functions, high biocompatibility and negligible immunogenicity for precise cancer therapy. In this review, we summarize the most recent advances in the development of cell primitive-based functional materials for cancer therapy. Different cell primitives, including bacteria, phages, cells, cell membranes, and other bioactive substances are introduced with their unique bioactive functions, and strategies in combining with synthetic materials, especially nanoparticulate systems, for the construction of function-enhanced biomaterials are also summarized. Furthermore, foreseeable challenges and future perspectives are also included for the future research direction in this field.